Qilian International Holding Group Limited (BGM) - Total Assets
Based on the latest financial reports, Qilian International Holding Group Limited (BGM) holds total assets worth $433.81 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Qilian International Holding Group Limited - Total Assets Trend (2017–2025)
This chart illustrates how Qilian International Holding Group Limited's total assets have evolved over time, based on quarterly financial data. Also see Qilian International Holding Group Limit market cap and net worth for the company's overall valuation and market capitalisation.
Qilian International Holding Group Limited - Asset Composition Analysis
Current Asset Composition (September 2025)
Qilian International Holding Group Limited's total assets of $433.81 Million consist of 11.9% current assets and 88.1% non-current assets. Review Qilian International Holding Group Limit debt and liabilities to assess the company's total debt and financial obligations.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.3% |
| Accounts Receivable | $17.05 Million | 3.9% |
| Inventory | $23.68 Million | 5.5% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $4.49 Million | 1.0% |
| Goodwill | $350.85 Million | 80.9% |
Asset Composition Trend (2017–2025)
This chart illustrates how Qilian International Holding Group Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See BGM stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Qilian International Holding Group Limited's current assets represent 11.9% of total assets in 2025, a decrease from 65.8% in 2017.
- Cash Position: Cash and equivalents constituted 2.3% of total assets in 2025, down from 16.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 81.0% of total assets, an increase from 6.0% in 2017.
- Asset Diversification: The largest asset category is goodwill at 80.9% of total assets.
Qilian International Holding Group Limited Competitors by Total Assets
Key competitors of Qilian International Holding Group Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Kamada
TA:KMDA
|
Israel | ILA377.21 Million |
|
Takeda Pharmaceutical Co Ltd ADR
NYSE:TAK
|
USA | $15.42 Trillion |
|
Viatris Inc
NASDAQ:VTRS
|
USA | $35.04 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
|
China | CN¥10.21 Billion |
|
Yipinhong Pharmaceutical Co Ltd Class A
SHE:300723
|
China | CN¥4.49 Billion |
|
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
|
USA | $199.45 Million |
Qilian International Holding Group Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.24 | 3.39 | 2.04 |
| Quick Ratio | 0.67 | 2.82 | 1.39 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $9.95 Million | $20.99 Million | $19.09 Million |
Qilian International Holding Group Limited - Advanced Valuation Insights
This section examines the relationship between Qilian International Holding Group Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.31 |
| Latest Market Cap to Assets Ratio | 0.23 |
| Asset Growth Rate (YoY) | 718.5% |
| Total Assets | $433.81 Million |
| Market Capitalization | $98.58 Million USD |
Valuation Analysis
Below Book Valuation: The market values Qilian International Holding Group Limited's assets below their book value (0.23x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Qilian International Holding Group Limited's assets grew by 718.5% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Qilian International Holding Group Limited (2017–2025)
The table below shows the annual total assets of Qilian International Holding Group Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-09-30 | $433.81 Million | +718.46% |
| 2024-09-30 | $53.00 Million | +3.41% |
| 2023-09-30 | $51.26 Million | -20.56% |
| 2022-09-30 | $64.53 Million | -14.37% |
| 2021-09-30 | $75.35 Million | +56.52% |
| 2020-09-30 | $48.14 Million | +36.51% |
| 2019-09-30 | $35.27 Million | +5.79% |
| 2018-09-30 | $33.34 Million | -0.13% |
| 2017-09-30 | $33.38 Million | -- |
About Qilian International Holding Group Limited
BGM Group Ltd., through its subsidiaries, operates as a pharmaceutical and chemical company in China. It offers oxytetracycline products, including Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline active pharmaceutical ingredients, which are used by pharmaceutical companies in the manufactu… Read more